>>SALT LAKE CITY, March 29 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP - News) announced today that it will report top line results from its pivotal Phase III study of PREOS® on March 30, 2004. The company will discuss the results during a conference call and webcast at 8:30 a.m. EST featuring Dr. Hunter Jackson, Chairman, CEO, and President, and other members of the NPS senior management team.
(Logo: newscom.com
To participate in the conference call, dial (800) 374-0232 and use confirmation code 6400995. International callers may dial (706) 634-6338, using the same confirmation code. In addition, live audio of the conference call will be simultaneously broadcast over the Internet and may be accessed under the Investor Relations page, Calendar of Events section of the company's web site (www.npsp.com). Please click on the webcast link and follow the prompts for registration and access.
If you are unable to participate in the live call, a replay will be available at (800) 642-1687 (with confirmation code 6400995) until midnight, EST, April 6, 2004. International callers may access the replay by dialing (706) 645-9291, using the same confirmation code. The webcast will also be available on the NPS website for the same period of time.<<
Would have been happier if they did it this evening. Now I have to get up at 5:00. Grrr. Results had better be good for that kind of sleep sacrifice.
Cheers, Tuck |
